These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19245211)

  • 1. Synthesis and pharmacological characterization of beta2-adrenergic agonist enantiomers: zilpaterol.
    Kern C; Meyer T; Droux S; Schollmeyer D; Miculka C
    J Med Chem; 2009 Mar; 52(6):1773-7. PubMed ID: 19245211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of the beta-adrenergic receptor agonist zilpaterol on the LPS-induced production of TNF-alpha in vitro and in vivo.
    Verhoeckx KC; Doornbos RP; van der Greef J; Witkamp RF; Rodenburg RJ
    J Vet Pharmacol Ther; 2005 Dec; 28(6):531-7. PubMed ID: 16343285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In search of secreted protein biomarkers for the anti-inflammatory effect of beta2-adrenergic receptor agonists: application of DIGE technology in combination with multivariate and univariate data analysis tools.
    Verhoeckx KC; Gaspari M; Bijlsma S; van der Greef J; Witkamp RF; Doornbos RP; Rodenburg RJ
    J Proteome Res; 2005; 4(6):2015-23. PubMed ID: 16335946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and beta-adrenergic activity of a series of 3-(substituted-benzylideneaminoxy)propanolamine derivatives.
    Gentili D; Lapucci A; Macchia B; Macchia M; Martinelli A; Nencetti S; Orlandini E; Ferni G; Pinza M
    Farmaco; 1995; 50(7-8):519-26. PubMed ID: 7669190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery.
    Topiol S; Sabio M
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1598-602. PubMed ID: 18243704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach.
    Procopiou PA; Barrett VJ; Bevan NJ; Biggadike K; Box PC; Butchers PR; Coe DM; Conroy R; Emmons A; Ford AJ; Holmes DS; Horsley H; Kerr F; Li-Kwai-Cheung AM; Looker BE; Mann IS; McLay IM; Morrison VS; Mutch PJ; Smith CE; Tomlin P
    J Med Chem; 2010 Jun; 53(11):4522-30. PubMed ID: 20462258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective sulfation of beta 2-receptor agonists by the human intestine and the recombinant M-form phenolsulfotransferase.
    Hartman AP; Wilson AA; Wilson HM; Aberg G; Falany CN; Walle T
    Chirality; 1998; 10(9):800-3. PubMed ID: 9839429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptamine-based human beta3-adrenergic receptor agonists. Part 1: SAR studies of the 7-position of the indole ring.
    Mizuno K; Sawa M; Harada H; Tateishi H; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):5959-62. PubMed ID: 15546707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solubilisation and binding characteristics of a recombinant beta2-adrenergic receptor expressed in the membrane of Escherichia coli for the multianalyte detection of beta-agonists and antagonists residues in food-producing animals.
    Danyi S; Degand G; Duez C; Granier B; Maghuin-Rogister G; Scippo ML
    Anal Chim Acta; 2007 Apr; 589(2):159-65. PubMed ID: 17418176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric separation of beta2-agonists on macrocyclic antibiotic chiral stationary phases in high performance liquid chromatography.
    Zhang D; Cheng M; Hyun MH; Xiong Z; Pan L; Li F
    Pharmazie; 2007 Nov; 62(11):836-40. PubMed ID: 18065099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Matsui T; Takasu T; Ohta M
    Eur J Med Chem; 2009 Jun; 44(6):2533-43. PubMed ID: 19232786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-adrenoceptor.
    Sartania N; Appelbe S; Pediani JD; Milligan G
    Cell Signal; 2007 Sep; 19(9):1928-38. PubMed ID: 17561373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
    Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
    Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of beta2-agonists by ion chromatography with direct conductivity detection.
    Shen S; Ouyang J; Baeyens WR; Delanghe JR; Yang Y
    J Pharm Biomed Anal; 2005 Jun; 38(1):166-72. PubMed ID: 15907636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay development for the beta-adrenergic agonist zilpaterol.
    Shelver WL; Smith DJ
    J Agric Food Chem; 2004 Apr; 52(8):2159-66. PubMed ID: 15080615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands.
    Karellas P; McNaughton M; Baker SP; Scammells PJ
    J Med Chem; 2008 Oct; 51(19):6128-37. PubMed ID: 18783211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled short-acting beta2 agonist.
    Nurs Times; 2004 Nov 16-22; 100(46):31. PubMed ID: 15595483
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues.
    Bonnert RV; Brown RC; Chapman D; Cheshire DR; Dixon J; Ince F; Kinchin EC; Lyons AJ; Davis AM; Hallam C; Harper ST; Unitt JF; Dougall IG; Jackson DM; McKechnie K; Young A; Simpson WT
    J Med Chem; 1998 Dec; 41(25):4915-7. PubMed ID: 9836607
    [No Abstract]   [Full Text] [Related]  

  • 20. BMS-201620: a selective beta 3 agonist.
    Washburn WN; Sun CQ; Bisacchi G; Wu G; Cheng PT; Sher PM; Ryono D; Gavai AV; Poss K; Girotra RN; McCann PJ; Mikkilineni AB; Dejneka TC; Wang TC; Merchant Z; Morella M; Arbeeny CM; Harper TW; Slusarchyk DA; Skwish S; Russell AD; Allen GT; Tesfamariam B; Frohlich BH; Abboa-Offei BE; Cap M; Waldron TL; George RJ; Young D; Dickinson KE; Seymour AA
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3525-9. PubMed ID: 15177466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.